Christina Applegate’s reversal draws attention to how often MS is misdiagnosed
Christina Applegate said she had lived with a diagnosis of multiple sclerosis for five years before learning she had not been given the correct answer. The revelation landed with the force of a clinical undoing: a disease identity she had built around daily symptoms, treatment decisions, and years of uncertainty was suddenly stripped away.
The actress described the news as deeply upsetting and said she was not relieved when the diagnosis changed. For patients, that reaction is understandable. A neurologic label can become the organizing principle for every unexplained symptom, every scan, and every bad day. When that label falls away, the body does not instantly make sense again, and the suffering does not disappear with the chart revision.
Applegate said an infusion treatment was stopped for a period to see how her body would respond. During that time, the pattern did not behave as expected for multiple sclerosis, prompting clinicians to look again at the underlying cause of her symptoms. The new conclusion was that she did not have the autoimmune disease after all.
Why multiple sclerosis is vulnerable to diagnostic error
MS is not diagnosed with a single definitive test. That is the central problem. Instead, clinicians assemble a diagnosis from history, neurologic examination, MRI findings, and laboratory work, then eliminate other explanations one by one. The process is rigorous, but it is also vulnerable to error when symptoms are incomplete, atypical, or overlap with other disorders.
Dr Marwa Kaisey described the condition as a diagnosis built from criteria rather than a universal yes-or-no test. In practice, that means the signal can be noisy. White matter lesions on MRI may support MS, but they are not exclusive to MS. Vascular risk factors such as high blood pressure, high blood sugar, and high cholesterol can contribute to white matter changes as well, and migraine can leave a similar radiologic footprint. A scan alone can point clinicians in the wrong direction if it is not interpreted in the context of the full clinical picture.
One of the most clinically important mimics is vitamin B12 deficiency. B12 deficiency can produce cognitive changes, tingling, gait instability, and balance problems, all of which can resemble demyelinating disease. Those overlaps are exactly why diagnostic discipline matters so much in neurology. A patient can carry a plausible MS label for years while a different, treatable disorder continues unchecked in the background.
The human cost of a diagnosis that later disappears
Dr Michael Kornberg described the psychological force of a misdiagnosis in direct terms. A chronic neurologic diagnosis does not sit on the edge of a patient’s life; it becomes part of identity. Once that happens, the loss is not just diagnostic accuracy. It is also the loss of certainty, continuity, and a framework for understanding symptoms that may already be disabling.
Applegate said she felt worse, not better, after learning she did not have MS. That response exposes a truth clinicians see often but do not always say out loud: the removal of a diagnosis does not automatically restore health. It can create a second injury, especially when the patient still has pain, weakness, fatigue, or impaired mobility and now has no clear explanation for them.
Her comments also reveal the practical burden of diagnostic backtracking. Years of treatment, surveillance, and adaptation may have been organized around a condition that no longer fits. The patient is left with fresh uncertainty and the same symptoms, which can be more destabilizing than the original label because it replaces a known disease with an unresolved search.
How frequently MS is diagnosed incorrectly
Elena Grebenciucova said research suggests that about 15 to 20 percent of patients diagnosed with MS do not actually have the disease. Even without a full breakdown of those cases, the figure is large enough to matter in routine neurology practice. It means that in a condition already defined by variability, a meaningful minority of patients may be living under the wrong diagnosis.
That kind of error often reflects the structure of MS evaluation rather than careless medicine. Clinicians are asked to interpret evolving neurologic symptoms against imperfect imaging and incomplete histories. When the disease course is unusual, when imaging findings are nonspecific, or when another disorder has not been fully excluded, the diagnosis can drift toward MS too early.
Dr Philip De Jager described MS as a diagnosis of exclusion, which is the right clinical framing. The work involves asking what else could explain the symptoms, then testing those possibilities against laboratory data, imaging, and time. In a disorder with no single confirmatory assay, second opinions are not a luxury. They are part of good neurologic care.
Bedside lessons from a public misdiagnosis
This case does not change the biology of MS, but it does sharpen the stakes of diagnostic precision. When a disease can be confused with migraine-related lesions, vascular changes, nutritional deficiency, or other neurologic syndromes, the burden falls on clinicians to slow down before anchoring on a label. MRI abnormalities have to be read carefully, symptoms have to be matched to anatomy, and alternative causes have to stay on the differential long enough to be tested properly.
There is also a treatment consequence. Once a patient is labeled with MS, disease-modifying therapy, infusion schedules, monitoring plans, and long-term expectations can follow. If the diagnosis is wrong, those decisions may expose patients to unnecessary treatment while leaving the actual disorder untreated.
A second opinion can change the entire trajectory. For patients with persistent neurologic symptoms and an uncertain story, the safest approach is often to keep asking whether the pieces truly fit. In a disease defined by diagnostic criteria rather than a single test, that discipline is not optional.